In vitro cytotoxicity of 211At-labeled trastuzumab in human breast cancer cell lines: effect of specific activity and HER2 receptor heterogeneity on survival fraction
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine
Reference46 articles.
1. Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens;Press;J Clin Oncol,2002
2. Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer;Berchuck;Cancer Res,1990
3. Humanization of an anti-p185HER2 antibody for human cancer therapy;Carter;Proc Natl Acad Sci U S A,1992
4. Towards an immunotherapy for p185HER2 overexpressing tumors;Carter;Adv Exp Med Biol,1994
5. Efficacy and safety of Herceptin in women with metastatic breast cancer: results from pivotal clinical studies;Smith;Anticancer Drugs,2001
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A third generation PSMA-targeted agent [211At]YF2: Synthesis and in vivo evaluation;Nuclear Medicine and Biology;2024-07
2. Alpha‐emitters and targeted alpha therapy in cancer treatment;iRADIOLOGY;2023-08-22
3. Status of α-emitter Radioimmunoconjugates for Targeted Therapy;Current Radiopharmaceuticals;2023-06
4. Monoclonal Antibody and Targeted Toxin Therapy;Holland‐Frei Cancer Medicine;2022-10-21
5. Recent progress of astatine-211 in endoradiotherapy: Great advances from fundamental properties to targeted radiopharmaceuticals;Chinese Chemical Letters;2022-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3